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Measurement of Stereopsis forms an important part of the clinical assessment of patients with disorders of ocular motility. The
introduction of a real depth distance stereoacuity test (FD2) was evaluated in clinical practice and to what extent the introduction
aﬀected clinical management. Seventy-three patients under evaluation before and following the introduction of the test were
included. Combined thresholds were measured at near using the Frisby and TNO test and at distance using the FD2. Fifty
healthy controls were included. Forty-ﬁve patients demonstrated Stereopsis using the FD2 and 23 of these had a change in their
management based in part on their responses using the FD2. Patients with evidence of Stereopsis using the FD2 were signiﬁcantly
more likely to have change in their management than expected from the whole sample (P = .02). The introduction of a real depth
distance stereoacuity test into clinical practice contributed to a change in management when used in conjunction with other tests.
The usefulness of the FD2 is limited by its range at 6m. Use at closer distances necessitates the calculation of binocular threshold
from the combined and monocular threshold.
Copyright © 2009 B. J. Young et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Stereopsis is routinely measured at near as part of the clinical
assessment of patients with disorders of ocular motility and
strabismus. Recently the FD2 [1, 2] has been introduced
in order to measure stereopsis at distance. The present of
stereopsis at a given distance indicates that a patient has
binocularcontrolatthatposition.Binocularcontrolcanvary
with distance depending on the state of the patient’s ocular
alignment. It is important therefore, to assess stereopsis at
diﬀerent distances in the clinical environment.
Stereopsis is usually reserved for the impression of depth
arising from binocular disparity [3–5]. There are, however,
manyotherbinocular(vergence,luminance,chromostereop-
sis, texture, etc.) and monocular (parallax, size, luminance,
etc.) cues that provide important depth information [6, 7].
These cues vary in the diﬀerent stereoacuity tests, whether
real object (Frisby, VDS, FD2) or simulated (TNO, BVAT,
Titmus). The sum of these cues contributes to a combined
threshold of depth discrimination (CT) [8]w h i c hi sa c t u a l l y
what is measured by most available stereoacuity tests. It is
because these cues vary in diﬀerent tests and with diﬀerent
viewing distances and gaze positions, that diﬀerences in
measured “stereoacuity” thresholds are often found.
Until the introduction of distance stereoacuity tests,
assessment of binocular alignment when viewing distant
objects relied upon the absence of a detectable heterotropia
and the response to Bagolini striated lenses or the Worth 4
Dot test. Neither test, however, provides suﬃcient informa-
tion to demonstrate the present of stereopsis. The FD2 is a
real object or depth rather than simulated stereoacuity test.
Although it is, therefore, not prone to disassociative stimuli,
because it is a real object test, it is prone to monocular cues
and limited in its range.
The use of the FD2 to evaluate the success of exotropia
surgery has been evaluated [9] but it is unclear, however,
whether the use of a real depth test such as the FD2
contributes to the actual clinical management of patients
with disorders of ocular motility. The contribution of the
FD2 to the management of a group of patients was therefore
investigated.2 Journal of Ophthalmology
Table 1: Depth discrimination thresholds of control subjects using the near stereoacuity tests, Frisby, TNO, and the FD2 at 1m, 3m, and
6m. Combined (CT), monocular (MT), and binocular (BT) depth discrimination thresholds. Mean, standard deviation (SD) and median
in logarithm of arc seconds. Range of test and subjects in arc seconds. Not measurable (NM).
Test
Mean CT
(SD) Median
(Logseconds)
Range of CT
(seconds)
Measurable range of
stereoacuity test
(seconds)
Mean BT
(SD) Median
(Logseconds)
Mean MT
(SD) Median
(Logseconds)
TNO 1.75 (040)
1.78 15–1980 15–1980 1.75 (0.40)
1.78 NM
Frisby 1.74 (0.34)
1.83 20–170 20–600 1.74 (0.34)
1.83 NM
FD2 6M 1.14 (0.28)
1.18 5–50 5–50 1.14 (0.28)
1.18 NM
FD2 3M 1.45 (0.23)
1.30 20–160 140–200 1.47 (0.25)
1.30
2.34 (0.2)
2.30
FD2 1M 2.28 (0.39)
2.26 182–558 952–2042 2.32 (0.10)
2.31
3.13 (0.15)
3.14
2. Methods
A retrospective case note review of 73 consecutive adult
patients with disorders of ocular motility who, had been
under review before and following the introduction of
the FD2 were included. They were divided into 4 groups
according to whether their depth discrimination could be
measured for; both near and distance, only at one distance,
or not at either distance. Patients in each group were then
assessed according to whether there had been a change in
their management and whether this was based in part on
the information provided by the FD2. A prospective study
was undertaken on 50 healthy individuals to determine the
monocularthresholdsandnormativedataofthestereoacuity
tests that had been used.
2.1. Ocular Alignment and Visual Acuity. Ocular deviations
were measured (using alternate prism and cover test) in
prism dioptres (rounded to nearest 2PD for deviations up
to and including 20PD, and the nearest 5PD for deviations
greater than 20PD). Monocular near and distance best
corrected visual acuity (BCVA) was measured at 6m using
Snellen chart and at 0.33m, using a near reading type.
2.2.MeasurementofDepthDiscrimination. Stereoacuitytests
were used according to the manufacturer’s instructions.
Depth discrimination thresholds were measured at near
(between 0.3m and 0.8m) using either the TNO or Frisby
stereoacuity tests in the normal reading position (i.e., on
downgaze) and at distance (6m) using the FD2. The range of
thresholds for the Frisby for each of the 3 plates can only be
varied by changing the viewing distance, and the measured
thresholds were at the distances speciﬁed between 0.3m and
0.8m by the manufacturer. The FD2 comprises of a box
containing four back illuminated shapes mounted on rods,
in a transparent support frame. Each of the shapes can be
moved so that one of them is set nearer than the other three
shapes. The rods are marked, so that disparity can be set
between 5 and 50 seconds of arc in steps of 5 seconds. The
FD2 was positioned at the correct measured height for each
subject’s eye level, and patients were asked not to move their
head during testing. The subjects were required to identify
three out of four correct choices at a given disparity until the
patient reached threshold. In the control group thresholds
of depth discrimination were measured with both eyes open
(combined threshold, (CT)) and then with one eye occluded
(monocular threshold, (MT)) for both the near Frisby and
FD2 at 6m, 3m, and 1m. The binocular threshold (BT) was
calculated, according to the function, BT = (1/CT-1/MT)
−1
[6].
2.3. Analysis. Chi-squared test was used to test for a
diﬀerence between the patient groups. The logarithm of
the depth discrimination threshold (combined, monocular,
and binocular) was used for the analysis. For comparison
betweenthestereoacuitytestsinthecontrolgrouparepeated
measures model was used.
3. Results
3.1. Control Group. 50 healthy subjects (mean age 38 years
(12)) were included. Using the FD2, MT was not measurable
at 6m. At 3m MT was measurable in 10% and at 1m in
60% of subjects (Table 1). There were linear but relatively
weak associations between the FD2 at 6m and the Frisby
(R2 = 0.40, P<. 001) and TNO (R2 = 0.28, P<. 001)
tests. There was also a signiﬁcant association between age
and depth discrimination (both near P = .003 and distance
P = .002).
3.2. Patients. 73 adult patients were included (mean age
58.3 years (19.5)). There were 39 patients whose depth
discrimination thresholds could be measured at both dis-
tances (FD2 and near test positive), and 6 patients whose
depth discrimination could not be measured with either
test (FD2 and near test negative). There were 22 patients
whose depth discrimination thresholds could be measured
at near only, and 6 patients whose depth discrimination
could be measured at distance only. Nine of the patients who
had incongruous results with the near and FD2 tests had aJournal of Ophthalmology 3
change in management. Overall 23 patients had a change in
management, the FD2 contributing in part to this decision
(Table 2).
3.3. FD2 Positive, Near Negative. Six patients (68–73 Table 2)
had stereoacuity measurable only on the FD2. Four of
these patients had torsional misalignment more evident for
near on depression. Two patients had a variable angle at
near with no measurable near depth discrimination. Prior
to the introduction of the FD2 these six patients had
been thought to have no useful stereopsis based on near
stereoacuity tests placed in the normal reading position, that
is, downgaze. Using the FD2 however they had measurable
depth discrimination (mean 38.3 seconds) at 6m with a
prism in place. Prisms were therefore prescribed.
3.4. FD2 Negative, Near Positive. Patients 20 and 22 (Table 2)
had no stereopsis measurable at distance. The ﬁrst patient,
had his prism reduced on his distance spectacle segment,
as using the FD2 no achievable stereopsis could be demon-
strated at distance. A second patient, who had previously
demonstrated 15 seconds with the FD2, lost this function
due to a change in his ocular alignment associated with
deterioration of his thyroid eye disease. This patient did
not show any change in his near depth threshold, which
remained at 55 seconds. A third patient (number 21) had a
decompensating exophoria and was found to have lost their
distance stereopsis (previously 50 seconds) and 2 lines of
BCVA (from 6/5 to 6/9) but with no change in their near
stereoacuity. This patient was found to have had a recurrent
retinal detachment and was therefore excluded from further
analysis.
3.5. FD2 and Near Positive. Patients 48 to 61 (Table 2)h a d
stereoacuity measurable on both the FD2 and near tests. In
tenofthesefourteenpatients,theFD2wasusedtodetermine
at what distance a prism was required and how much prism
was necessary to gain stereoacuity. In patients undergoing
surgery for strabismus, the FD2 was used to conﬁrm the
presence of quantiﬁable binocular function at the corrected
angle for distance in free space.
Overall, patients who had evidence of depth discrimina-
tion stereopsis using the FD2 were signiﬁcantly more likely
to have some modiﬁcations to their clinical management
than expected from the whole patient sample (P = .023).
This was particularly so for patients who had evidence of
depth discrimination on the FD2 but not using the near tests
(P<. 001).
4. Discussion
The most commonly used stereo tests in clinical practice
are usually viewed at near. In addition, many adult patients
wear bifocals or varifocals requiring that the near stereo
tests be placed in their normal reading position. Distance
stereoacuity using the FD2 is measured at eye level. One
therefore cannot assume that because an individual has
stereoacuity at near or in a reading position, that they will
also have stereoacuity at distance in the primary position.
For example, in this study some patients achieved 25 seconds
usingtheFD2butonlyachieved120secondsusingtheFrisby
at 0.4m. It is unclear whether this diﬀerence arose because
of changes in ocular position or diﬀerences in the inherent
monocular and binocular cue content in each test. This is
apparent in the relatively poor correlation between near tests
and FD2.
Importantly we found that for the patients in this study,
the demonstration of stereopsis at distance contributed to
a change in their management. Although it is diﬃcult to
be sure of the true contribution of the FD2 to the change
in management given that a change in condition could
have occurred before and after introduction of FD2, this is
unlikely as most of the patients’ ocular motility was relatively
stable. Similarly whilst it is possible that a similar proportion
of patients may have had a change in their management in
the absence of the results of the FD2, this is also unlikely,
given that the management decisions were inﬂuenced by the
results of the FD2.
The relatively poor association between the TNO, Frisby,
and FD2 for the healthy control where the maximum
association was 40% and for patient group, where there was
no signiﬁcant association, is likely to reﬂect the diﬀerences in
the monocular and binocular cue content of these tests. For
example, although vertical disparity, accommodation, and
vergence are potentially important binocular cues for near
tests, they may play less of a role in distance stereoacuity tests
[6, 10–18]. These diﬀerences in monocular and binocular
cues are also likely to account in part for the diﬀerences
in measured thresholds. For example, although all of the
patients who were near positive but distance negative had
near stereoacuity values greater than 50 seconds, there were
many patients who had near and distance stereoacuity with
distance stereoacuity less than 50 seconds, despite their near
stereoacuity values being greater than 50 seconds of arc.
The targets used in the near stereoacuity tests have
minimum and maximum thresholds of 15 seconds and 1980
seconds (TNO) and 20 seconds and 600 seconds (Frisby).
In contrast the FD2 at 6m has a minimum and maximum
threshold of 5 seconds and 50 seconds. This together with
the noncontinuous or stepwise increments in all of these
stereoacuity tests means that there is little overlap between
the near tests and the FD2.
This limitation may account for those patients who
had thresholds greater than 50 seconds with near tests
but who had no demonstrable stereopsis using the FD2 at
6m. Shortening of the viewing distance to 3m extends the
maximum threshold with the FD2, but also leads to an
increase in monocular cues [19], see Table 1.M o n o c u l a r
cues facilitate depth perception and form an integral part
of the stereo mechanism [6, 20], and it has been shown
that monocular cues may contribute to depth even when
they do not reach threshold [6]. Previous investigations
of the FD2 have reported a problem with the monocular
cue content [21] thus necessitating either a change in
protocol or measurement of the monocular threshold. As
discussed, although stereopsis is usually reserved for the
impression of depth arising from binocular disparity [3–
5, 8] horizontal and nonhorizontal [12, 20] other binocular4 Journal of Ophthalmology
Table 2: Patients who had a change in clinical management following introduction of FD2. Patients 68–73 had evidence of stereopsis using
theFD2butnotwithneartests,patients20–22,stereopsiswiththeneartestsbutnotFD2andpatients48–61evidenceofstereopsiswithboth
the FD2 and near tests, respectively. Patient 21 was excluded from further analysis as the change was due to retinal detachment. Summary
of the change in management is included in the right-most column. Diagnosis is included where established. Where no speciﬁc diagnosis
established,extraocularmuscledeviationrecorded.Prismdioptres(pd),intermittentheterotropia(T),esophoria(EP),esotropia(ET),hyper
or hypotropia (HT), hyper or hypophoria (HP), base-out (BO), and base-in (BI) prism, lateral rectus (LR), superior rectus (SR), superior
oblique (SO), medial rectus (MR), inferior rectus (IR), right (R) and left (L), underaction (u/a), thyroid eye disease (TED).
Patient Symptom
Deviation
Diagnosis/lesion FD2(sec) Near(sec) Change in
management Distance Near
68 Diplopia on
depression
3pd HP, 50
cyclotorsion
4pd HT, 150
cyclotorsion (L)IVn paresis 50 with prism nil Prism accepted over
entire varifocal
69 Intermittent
diplopia 3pd HT 2pd ET, 2pd
HT
B i l a t e r a lI Ru / a .P i n e a l
germinoma 25 with prism nil
Given weakest prism
possible to achieve
distance stereo.
70 Diplopia 10pd ET, 5pd
HT
16pd ET, 6pd
HT
cyclotorsion
LR and (L) SR and (R)
SO u/a 25 with prism nil
BO prism achieved
dist stereo, but not for
near
71
Increasing
diplopia on
downgaze
12pd E(T)
8pd E(T),
14pd ET on
downgaze
Bilat VIn paresis.
Acoustic neuroma 50 with prism nil
Increased BO prism
for distance to achieve
distance stereo.
72 Diplopia 7pd HT
7pd HT, 7pd
XT
cyclotorsion
(L) IVn paresis 30 with prism nil Vertical prism
accepted for distance.
73
Reversal of
diplopia at near
with prism
4pd HT 2pd HT
cyclotorsion (R) SR, (L) SO u/a 50 with prism nil
Vertical prism
accepted only for
distance.
20 Intermittent
diplopia
10pd ET, 4pd
H(T) 2pd EP Bilateral VIn (L) SR u/a nil with
prism
120 with
prism
No diplopia with
reduced prism. FD2
negative with
deviation corrected
21 Intermittent
diplopia 8pd XP 25pd XP Decompensated XP
Retinal detachment nil 240
FD2 positive
previously. Referred
to vitreo retinal team.
22 Intermittent
diplopia 4pd EP(T) 2pd EP TED. Proptosis L > R nil 55
Orbital
decompression. FD2
positive previously.
48 Diplopia on
depression 7pd HP 7pd H(T) IR u/a 30 300 with
prism
Prism only on reading
segment
49 Intermittent
diplopia 6pd E(T) 2pd EP (L)VIn 50 with prism 150 Prism over distance
segment
50 Intermittent
diplopia 2pd H(T) 10pd XP TED 30 with prism 85 Prism over distance
segment
51 Asymptomatic 2–4 pd E(T) 6pd XP (R)VIn 50 with prism 480 Binocular with prism
over distance segment
52 Intermittent
diplopia 8pd E(T) 4pd EP Bilat VIn 50 with prism 60
Increased prism to
achieve distance
stereoacuity
53 Resolving
diplopia 6pd EP 2pd EP (L)VIn resolving 15 55 Binocular without
prism
54
Intermittent
diplopia for
near objects
12pd XP 35pd X(T) Decompensating XP 50 without
prism
600 with
10pd BI
prism
Prism removed from
distance segment
55 Blurred vision. 0 with
spectacles
4pd XP to
variable ET
Intermittent
accommodative spasm
15 with
spectacles 60 Accepted spectacles to
achieve binocularity.
56
Intermittent
diplopia for
distant objects
2–4pd HT 2pd HP (R) SR u/a 15 with prism 60 Binocular only with
prismJournal of Ophthalmology 5
Table 2: Continued.
Patient Symptom
Deviation
Diagnosis/lesion FD2(sec) Near(sec) Change in
management Distance Near
57
Diplopia
(monocular and
binocular)
2pd EP 6pd X(T) MR u/a
Polyopia/correctopia
15 with and
without
prism
110 Removed prism for
distance
58 Diplopia at near 4∧XP 10
∧X(T) Decompensating XP 40 1980 without,
85 with prism
Separate reading
glasses with prism
incorporated
59 Intermittent
diplopia 6∧ET 4∧EP Bilateral VIn 50 with prism 120
Not aware of diplopia
but binocular only
with prism
60 Diplopia 6∧H(T) 4∧HP Partial IIIn 30 with prism 150
Binocular with
prisms. For
strabismus surgery.
61
Intermittent
diplopia and
aesthenopia
10XP 0 Decompensating XP 20 55
Distance exercises and
consideration for
surgery
(vergence, luminance, chromostereopsis, texture, etc.) and
monocular (parallax, size, luminance, etc.) cues provide
important depth information [6, 7]. These cues summate
i na n ys t e r e o a c u i t yt e s ts ot h a tw h a ti sm e a s u r e di sa
combined threshold of depth discrimination [8]. It has,
however, been shown that subtraction of the monocular
threshold from the combined threshold allows calculation of
the actual binocular threshold (BT) of depth discrimination
[6] which, is what is of interest when assessing binocularity.
Thus when measuring a patient’s level of stereoacuity if
monocular cues reach threshold, rather than abandoning the
test, the monocular threshold should be subtracted from the
binocular threshold according to the function, BT = (1/CT-
1/MT)
−1 [6, 7, 19, 20].
Other distance stereoacuity tests have been introduced
such as the Mentor Binocular Video Acuity Tester (BVAT)
[22–24] and the Variable Distance Stereotest (VDS) [3,
6]. The importance of measuring stereoacuity at distance
has been particularly well demonstrated using the BVAT
and VDS. The BVAT is a simulated distance stereotest.
The test requires the use of goggles that are potentially
disassociative and do not facilitate the correction of any
deviation using prisms. The BVAT being a simulated test has
zero parallax, which implies that the object is ﬂat. The VDS
based on the classic three-rod arrangement of Helmholtz
[25], and although providing a continuous measurement of
stereoacuity in seconds of arc has never been commercially
available.
The introduction into clinical practice of the FD2 dis-
tance stereotest was found to contribute to clinical decision
making which otherwise may not have occurred using only
near stereoacuity tests. The FD2 is however limited by its
range at 6 meters and using the test at shorter distances
necessitates measurement of MT with calculation of the BT
as described above. Despite these limitations measurement
of stereoacuity at distance is an important aspect in the
evaluation of patients with disorders of ocular motility.
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